XPA

protein-coding

XPA, DNA damage recognition and repair factor, the group of Xeroderma pigmentosum complementation groups

Gene summary

This gene encodes a zinc finger protein plays a central role in nucleotide excision repair (NER), a specialized type of DNA repair. NER is responsible for repair of UV radiation-induced photoproducts and DNA adducts induced by chemical carcinogens and chemotherapeutic drugs. The encoded protein interacts with DNA and several NER proteins, acting as a scaffold to assemble the NER incision complex at sites of DNA damage. Mutations in this gene cause Xeroderma pigmentosum complementation group A (XP-A), an autosomal recessive skin disorder featuring hypersensitivity to sunlight and increased risk for skin cancer. [provided by RefSeq, Aug 2017]

MANE transcript

NM_000380.4

Inheritance

AR

ClinVar variants

P:126U:70B:120

Top phenotype

Xeroderma pigmentosum, group A

gnomAD constraint

pLI —, LoF o/e 0.56

Max pathogenic AF

—

Genomic locus

chr9:97,674,909-97,697,340

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~22.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

xeroderma pigmentosum group ADEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0010210

Submitter: ClinGen

There is abundant evidence published associating the XPA gene with xeroderma pigmentosum group A since the gene-disease relationship was first proposed by Tanaka et al. (1990). Multiple case level studies have been performed with XPA patients that have variants in the XPA gene. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. Multiple Xpa deficient mouse models have been established to show consistent phenotypes with XPA patients, including growth retardation, abnormal behavior, premature aging and UV or chemical induced skin tumours. All of these types of evidence are consistent with a definitive relationship between the XPA gene and xeroderma pigmentosum group A.

xeroderma pigmentosum group ASTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0010210

Submitter: Genomics England PanelApp

xeroderma pigmentosum group ADEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0010210

Submitter: G2P

xeroderma pigmentosum group ASTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0010210

Submitter: PanelApp Australia

xeroderma pigmentosum group ASTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0010210

Submitter: Labcorp Genetics (formerly Invitae)

xeroderma pigmentosumSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0019600

Submitter: Orphanet

xeroderma pigmentosum group ADEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0010210

Submitter: Myriad Women's Health

Clinical Genomic Database (CGD)

Xeroderma pigmentosum, group AAR

Manifestation: Dermatologic; Neurologic; Oncologic; Ophthalmologic

Intervention: Dermatologic; Oncologic; Ophthalmologic

Rationale: Skin lesions can be treated (and possibly prevented in some cases) with a variety of methods, depending on the specific type of lesion; Sun/UV exposure (and other agents, such as tobacco smoke) should be avoided; Periodic surveillance (primarily related to skin manifestations, as well as other sequelae) can be beneficial

Refs: 286113; 2168777; 2234061; 1571258; 1372102; 8053698; 9671271; 10447254; 20301571; 20534089; 20574439; 22044607; 22081045Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to XPA variants in ClinVar

7 Conditions Cataloged
not providedTotal: 279
Xeroderma pigmentosum group ATotal: 123
Xeroderma pigmentosumTotal: 42
Inborn genetic diseasesTotal: 35
not specifiedTotal: 18
XPA-related disorderTotal: 12
Ovarian cancerTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000380.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
111
clinvar
114
missense
10
clinvar
61
clinvar
8
clinvar
1
clinvar
80
nonsense
17
clinvar
11
clinvar
1
clinvar
29
start loss
1
clinvar
3
clinvar
1
clinvar
5
frameshift
35
clinvar
30
clinvar
3
clinvar
68
splice donor/acceptor (+/-2bp)
6
clinvar
13
clinvar
1
clinvar
20
Total5967701191316

Highest pathogenic variant AF is 0.00016981486

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 22 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000380.4RefSeqNP_000371.16MANE Select
ENST00000375128.5EnsemblENSP00000364270.56MANE Select
NM_001354975.2RefSeqNP_001341904.16Standard
ENST00000462523.5EnsemblENSP00000433006.16Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Nucleotide excision repair - Homo sapiens (human)
  • Nucleotide Excision Repair
  • DNA Repair
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER

Biological Process

  • nucleotide-excision repair, DNA damage recognition
  • DNA repair
  • transcription-coupled nucleotide-excision repair
  • base-excision repair
  • nucleotide-excision repair, preincision complex stabilization

Molecular Function

  • damaged DNA binding
  • protein binding
  • protein domain specific binding
  • protein homodimerization activity
  • metal ion binding

Cellular Component

  • nucleotide-excision repair factor 1 complex
  • nucleus
  • nucleoplasm
  • DNA replication factor A complex
  • cytoplasm

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000375128
Coding exons
6
Length
22449
Individuals with no LoFs
125614
Homozygous LoFs
0
Heterozygous LoFs
128
Defined
125742
p
0.000509
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3461391510.9210.000007311783
Missense (PolyPhen)2933.5280.86495415
Synonymous-0.4445752.91.080.00000262484
Loss of Function1.65916.20.5579.39e-7185

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000430.00043rare
Latino/Admixed American0.000140.00014rare
Ashkenazi Jewish00.0absent
East Asian0.000280.00027rare
Finnish0.00300.0030notable
European (Non-Finnish)0.000300.00030rare
South Asian0.000360.00036rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in DNA excision repair. Initiates repair by binding to damaged sites with various affinities, depending on the photoproduct and the transcriptional state of the region. Required for UV-induced CHEK1 phosphorylation and the recruitment of CEP164 to cyclobutane pyrimidine dimmers (CPD), sites of DNA damage after UV irradiation. {ECO:0000269|PubMed:19197159}.;
Disease
DISEASE: Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. XP-A patients show the most severe skin symptoms and progressive neurological disorders. {ECO:0000269|PubMed:10447254, ECO:0000269|PubMed:1339397, ECO:0000269|PubMed:1372103, ECO:0000269|PubMed:8504220, ECO:0000269|PubMed:9671271}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.553

Intolerance Scores

LoFtool
0.735
RVIS EVS
0.68
RVIS percentile EVS
84.93

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.943

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.